Page last updated: 2024-08-23

mifepristone and Histiocytoma, Malignant Fibrous

mifepristone has been researched along with Histiocytoma, Malignant Fibrous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Check, D; Check, JH; Cohen, R; Dix, E; Wilson, C1

Other Studies

1 other study(ies) available for mifepristone and Histiocytoma, Malignant Fibrous

ArticleYear
Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.
    Anticancer research, 2010, Volume: 30, Issue:2

    Topics: Adult; Aged; Carcinoma, Transitional Cell; Colonic Neoplasms; Female; Histiocytoma, Malignant Fibrous; Hormone Antagonists; Humans; Kidney Neoplasms; Leiomyosarcoma; Male; Middle Aged; Mifepristone; Neoplasms; Palliative Care; Pancreatic Neoplasms; Receptors, Progesterone; Survival Rate; Thymus Neoplasms; Treatment Outcome; Young Adult

2010